Related Experiment Videos
Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines
C W Wan1, M K McKnight, D E Brattain
1Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030.
Abstract:
The growth response to epidermal growth factor (EGF) and the numbers and types of EGF receptors were studied in three human colon tumor cell lines from each of two groups of cell lines that differ markedly in their growth properties and extent of differentiation. Aggressively growing and poorly differentiated colon cells (group I) did not respond to EGF alone, while less aggressively growing and more differentiated cells (group III) responded with increased growth when EGF was added to their chemically defined, serum-free medium. The average number of EGF receptors (EGF-R) measured at the surface of group III cell lines by radioligand binding assays, was eight-fold higher than that measured for group I cell lines. These observations provide evidence for possible autocrine mechanisms that maintain available EGF-R levels in more differentiated group III colon tumor cells and down-regulate EGF-R levels in group I colon tumor cells.
Insights
Human colon tumor cells show varied responses to epidermal growth factor (EGF). More differentiated cells with higher EGF receptor numbers grew with EGF, unlike aggressive, poorly differentiated cells.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Epidermal Growth Factor (EGF) plays a crucial role in cell growth and differentiation.
- Human colon tumor cell lines exhibit diverse growth patterns and differentiation states.
- EGF receptor (EGF-R) expression is a key factor in cellular response to EGF.
Purpose of the Study:
- To investigate the differential growth response of human colon tumor cell lines to EGF.
- To quantify and compare the number and types of EGF receptors in distinct colon tumor cell groups.
- To explore the potential role of EGF receptors in colon cancer progression and differentiation.
Main Methods:
- Culturing of three human colon tumor cell lines from two distinct groups based on growth and differentiation.
- Treatment with epidermal growth factor (EGF) in chemically defined, serum-free medium.
- Quantification of EGF receptors using radioligand binding assays.
Main Results:
- Poorly differentiated, aggressively growing colon tumor cells (Group I) showed no response to EGF alone.
- More differentiated colon tumor cells (Group III) exhibited increased growth upon EGF addition.
- Group III cell lines possessed an average of eight-fold higher EGF receptor numbers compared to Group I cells.
Conclusions:
- Colon tumor cell differentiation status correlates with EGF responsiveness.
- Higher EGF receptor levels in differentiated cells may support autocrine signaling.
- Down-regulation of EGF receptors in aggressive tumors could contribute to their unresponsiveness.